- KR₩36tn
- KR₩39tn
- KR₩4tn
Brief: Celltrion Seeks To Get EMA's Approval For Its Covid-19 Treatment's Formal Use
Brief: EMA Gets Application For Marketing Authorisation For Regkirona For Treating COVID-19
Brief: Celltrion Says Awarded Up To $626 Mln From Department Of Defense To Supply Covid-19 Point-Of-Care Rapid Antigen Test Kits
U.S. government to buy rapid COVID-19 tests from Abbott, Celltrion -official (updated)
U.S. government to buy point-of-care COVID-19 tests from Abbott, Celltrion -source
EU signs joint procurement deal for Eli Lilly COVID-19 treatment
South Korea approves Celltrion's COVID-19 treatment for use
EU evaluates Roche arthritis drug as COVID-19 treatment (updated)
EU picks antibody treatments, arthritis drug as preferred COVID-19 therapies
Astra antibody cocktail fails to prevent COVID-19 symptoms in large trial (updated)
What you need to know about the coronavirus right now
Celltrion says trial shows antibody COVID-19 treatment to be safe and effective
Brief: Celltrion's Anti-Covid 19 Monoclonal Antibody Treatment, Regdanvimab, Demonstrates Neutralising Effect Against South African Variant
EMA advises limited use of Celltrion COVID-19 drug, says benefits still unclear (updated)
EMA says benefits of Celltrion's COVID-19 antibody drug inconclusive, real-time review on
Brief: EMA Issues Advice On Use Of Regdanvimab For Treating COVID-19
EU regulator advises use of Regeneron antibody cocktail for COVID-19 (updated)
EU regulator says Celltrion's COVID-19 antibody drug under real-time review (updated)
EU drug watchdog reviews Celltrion's COVID-19 antibody treatment